A61P 5/14
Drugs for disorders of the endocrine system: of the thyroid hormones
Official title: of the thyroid hormones, e.g. T3, T4
A61P5/14 (Drugs for disorders of the endocrine system: of the thyroid hormones) appears on 3,258 US grants and 5,183 published applications in this corpus.
Search patents in A61P- Granted patents
- 3,258
- Published applications
- 5,183
- Assignees
- 1,381
- Inventors
- 8,278
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 3 | 0 |
| 1997 | 5 | 0 |
| 1998 | 10 | 0 |
| 1999 | 16 | 0 |
| 2000 | 20 | 0 |
| 2001 | 27 | 8 |
| 2002 | 57 | 91 |
| 2003 | 60 | 164 |
| 2004 | 50 | 206 |
| 2005 | 50 | 231 |
| 2006 | 73 | 224 |
| 2007 | 75 | 223 |
| 2008 | 102 | 272 |
| 2009 | 130 | 366 |
| 2010 | 189 | 393 |
| 2011 | 209 | 360 |
| 2012 | 236 | 357 |
| 2013 | 289 | 273 |
| 2014 | 243 | 347 |
| 2015 | 231 | 265 |
| 2016 | 202 | 249 |
| 2017 | 216 | 234 |
| 2018 | 154 | 192 |
| 2019 | 146 | 160 |
| 2020 | 145 | 151 |
| 2021 | 97 | 111 |
| 2022 | 71 | 90 |
| 2023 | 47 | 66 |
| 2024 | 48 | 59 |
| 2025 | 38 | 58 |
| 2026 | 16 | 33 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Pyridazinone compounds25 Aug 2026US 12,715,858 B2Inventisbio Co., Ltd.
- FcRn antibodies and methods of use thereof16 Jun 2026US 12,655,209 B2Momenta Pharmaceuticals, Inc.
- Anti-insulin-like growth factor 1 receptor (IGF-1R) antibodies and method of use thereof to treat thyroid-associated opthamology9 Jun 2026US 12,649,795 B2Suzhou Pro-heal Pharmaceuticals technology Co., Ltd.
- Fc region variant2 Jun 2026US 12,643,937 B2Chugai Seiyaku Kabushiki Kaisha
- Recombinant interferon with changed spatial configuration26 May 2026US 12,636,347 B2
- Treatment of thyroid eye disease with satralizumab1 Oct 2026US 2026/0297203 A1Chugai Seiyaku Kabushiki Kaisha
- Anti-tshr antibodies and uses thereof10 Sep 2026US 2026/0265387 A1Ethyreal Bio, Inc.
- Pharmaceutical oral solid dosage forms including liothyronine and levothyroxine salts and methods of making and using the same27 Aug 2026US 2026/0248751 A1Genus Lifesciences Inc.
- Combination of anti-cdh6 antibody-drug conjugate and hif-2alpha inhibitor27 Aug 2026US 2026/0248938 A1Daiichi Sankyo Company, Limited
- Fc region variant27 Aug 2026US 2026/0250360 A1Chugai Seiyaku Kabushiki Kaisha
Most cited
By later US patents
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions930US 6,248,363 B1Lipocine Inc. · 2001
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions684US 6,923,988 B2Lipocine Inc. · 2005
- Solid carriers for improved delivery of hydrophobic active ingredients in pharmaceutical compositions616US 6,569,463 B2Lipocine Inc. · 2003
- Modified antibody variable domains462US 5,766,886 AXoma Corporation · 1998
- Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents342US 6,309,663 B1Lipocine Inc. · 2001